Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Cytokeratin 19 Antikörper (AA 312-335)

KRT19 Reaktivität: Human, Maus, Ratte WB, IHC (p), IHC (fro) Wirt: Maus Monoclonal B303 (A53-B-A2) unconjugated
Produktnummer ABIN965960
  • Target Alle Cytokeratin 19 (KRT19) Antikörper anzeigen
    Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
    Bindungsspezifität
    • 16
    • 16
    • 15
    • 14
    • 8
    • 8
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 312-335
    Reaktivität
    • 268
    • 92
    • 72
    • 7
    • 7
    • 6
    • 5
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human, Maus, Ratte
    Wirt
    • 139
    • 136
    • 3
    • 2
    • 1
    Maus
    Klonalität
    • 147
    • 134
    Monoklonal
    Konjugat
    • 126
    • 32
    • 19
    • 12
    • 6
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    Dieser Cytokeratin 19 Antikörper ist unkonjugiert
    Applikation
    • 190
    • 96
    • 83
    • 83
    • 70
    • 45
    • 41
    • 39
    • 33
    • 31
    • 23
    • 22
    • 7
    • 6
    • 6
    • 5
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
    Aufreinigung
    Concentrated.
    Immunogen
    Keratin fraction isolated from Human Breast Cancer MCF-7 cells
    Klon
    B303 (A53-B-A2)
    Isotyp
    IgG2a
    Top Product
    Discover our top product KRT19 Primärantikörper
  • Applikationshinweise
    Immunohistochemistry: (Paraffin/Frozen): 1:50-1:100
    WB: 1:100-1:500.
    Staining Procedure: Prolonged fixation in buffered formalin can destroy the epitope. The antibody may be used at a dilution of 1:50 to 1:100 with. The optimal conditions should be determined by the individual laboratory. High temperature antigen unmasking technique predigestion is strongly recommended.
    Kommentare

    Cellular Localization: Cytoplasmic.
    Recommended Positive Control: Skin, Colonic Carcinoma

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    0.3 mg/ml
    Buffer
    20 mM Tris-Borate, 150 mM Sodium Chloride, dialyzed media RPMI 1640/D-MEM containing Fetal Bovine Serum, BMC-6 Carrier Polysaccharides, Carrier Protein, pH 7.5
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C
  • Target
    Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
    Abstract
    KRT19 Produkte
    Hintergrund
    This antibody reacts with Cytokeratin 19 (40 kD) intermediate filament and with a wide variety of Simple epithelia and non-squamous stratified epithelia. It does not react with stratified squamous epithelia. However, cervical squamous cell carcinomas show positivity with this antibody.
    Gen-ID
    3880
Sie sind hier:
Kundenservice